Guardant Health, Inc.
- Stock
- Ticker GH
- ISIN US40131M1099
- Nasdaq
Performance, volatility and drawdowns of Guardant Health, Inc. since 10/2018, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $12,487. Global equities (VT): $14,653.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −91.0% in 04/2024, measured from the peak in 02/2021. It took 67 months to get back to the old peak.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 202 | 203 | 232 | 265 | 281 | 302 | 335 | 361 |
| Gross profit | 124 | 129 | 151 | 172 | 182 | 197 | 219 | 236 |
| Operating income | -126 | -111 | -106 | -99 | -121 | -121 | -129 | -133 |
| EBITDA | -116 | -101 | -97 | -90 | -111 | -112 | -120 | -123 |
| Net income | -111 | -95 | -100 | -93 | -128 | -112 | -120 | -124 |
| Earnings per share | -0.90 | -0.77 | -0.80 | -0.74 | -1.00 | -0.85 | -0.90 | -0.93 |
| Balance sheet | ||||||||
| Total assets | 1,486 | 1,344 | 1,332 | 1,277 | 2,014 | 1,915 | 1,912 | 1,886 |
| Liabilities | 1,625 | 1,595 | 1,637 | 1,631 | 2,113 | 2,096 | 2,135 | 2,162 |
| Equity | -140 | -251 | -305 | -354 | -99 | -181 | -223 | -276 |
| Cash | 526 | 699 | 629 | 580 | 378 | 989 | 1,053 | 1,027 |
| Long-term debt | 1,143 | 1,116 | 1,116 | 1,115 | 1,504 | 1,503 | 1,503 | 1,502 |
| Cash flow | ||||||||
| Operating cash flow | -65 | -63 | -60 | -35 | -26 | -66 | -58 | -24 |
| Capital expenditure | -19 | -4.5 | -5.6 | -10 | -28 | -5.6 | -12 | -13 |
| Free cash flow | -83 | -67 | -66 | -46 | -54 | -71 | -70 | -37 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2025 at +234.3%, weakest 2022 at −72.8%. 4 of 7 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 5 Nov 2026 | −$0.93 |
| 30 Jul 2026 | −$0.90 |
| 7 May 2026 | −$0.85 |
| 19 Feb 2026 | −$1.00 |
| 29 Oct 2025 | −$0.74 |
| 30 Jul 2025 | −$0.80 |
| 30 Apr 2025 | −$0.77 |
| 20 Feb 2025 | −$0.90 |
| 6 Nov 2024 | −$0.88 |
| 7 Aug 2024 | −$0.84 |
| 9 May 2024 | −$0.94 |
| 22 Feb 2024 | −$1.62 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €18bn
- Market cap in trading currency
- $19.7bn
- Enterprise value
- $20.2bn
- P/E
- –
- P/S
- 15.43
- P/B
- –
- EV/Sales
- 15.80
- EV/EBITDA
- –
- Earnings yield
- –
- FCF yield
- -1.2%
Results (last four quarters)
- Revenue
- $1.28bn
- Gross profit
- $834m
- EBITDA
- −$465m
- Net income
- −$485m
- Earnings per share
- −$3.68
- Revenue per share
- $9.45
- Revenue growth
- +36.1%
- Earnings growth
- –
Profitability
- Gross margin
- 65.2%
- Operating margin
- -39.4%
- Net margin
- -37.9%
- Return on equity
- –
- Return on assets
- -25.7%
Balance sheet and cash flow
- Cash
- $1.03bn
- Cash per share
- $7.59
- Financial debt
- $1.50bn
- Debt/equity %
- –
- Current ratio
- 3.60
- Book value per share
- −$2.04
- Operating cash flow
- −$173m
- Free cash flow
- −$232m
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- –
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 135m
- Volume
- 2.76m
- Avg. volume 3 months
- 1.97m
- Relative volume
- 1.4
Price and technicals
- Price
- $145.83
- 1 day
- +0.2%
- 52-week high
- $187.22
- 52-week low
- $78.60
- Distance to 52-week high
- −22.1%
- Distance to 52-week low
- +85.5%
- Distance to 50-day line
- −12.7%
- Distance to 200-day line
- +9.1%
- RSI (14)
- 37
- Volatility 1M
- 55.0%
Performance
- 1 week
- −3.9%
- 1 month
- −10.5%
- 3 months
- −10.6%
- 6 months
- +22.6%
- YTD
- +42.8%
- 1 year
- +46.5%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has GH performed since 10/2018?
$10,000 grew to $45,289 by 20 Nov 2026, which is +20.4% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is GH?
Volatility was 71.4% per year, measured on monthly returns. The largest decline from a peak was −91.0%, with the low in 04/2024.
How does GH compare with a broad equity ETF?
Over the same period Global equities (VT) returned +10.4% per year at 16.2% volatility, GH returned +20.4% at 71.4%. The correlation of monthly returns was 0.28; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.